IL-31 induces antitumor immunity in breast carcinoma

BACKGROUND: Immunomodulatory agents that induce antitumor immunity have great potential for treatment of cancer. We have previously shown that interleukin (IL)-31, a proinflammatory cytokine from the IL-6 family, acts as an antiangiogenic agent. Here, we characterize the immunomodulatory effect of I...

Descripción completa

Detalles Bibliográficos
Autores principales: Kan, Tal, Feldman, Erik, Timaner, Michael, Raviv, Ziv, Shen-Orr, Shai, Aronheim, Ami, Shaked, Yuval
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449545/
https://www.ncbi.nlm.nih.gov/pubmed/32843492
http://dx.doi.org/10.1136/jitc-2020-001010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449545/
https://www.ncbi.nlm.nih.gov/pubmed/32843492
http://dx.doi.org/10.1136/jitc-2020-001010

Ejemplares similares